Literature DB >> 24657501

Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy.

Alan W C Yuen1, Josemir W Sander2.   

Abstract

There has been resurgence in the use of dietary treatment, principally the classical ketogenic diet and its variants, for people with epilepsy. These diets generally require significant medical and dietician support. An effective but less restrictive dietary regimen is likely to be more acceptable and more widely used. Calorie-restricted diets appear to produce a range of biochemical and metabolic changes including reduced glucose levels, reduced inflammatory markers, increased sirtuins, increased AMPK signaling, inhibition of mTOR signaling, and increase in autophagy. There are studies in animal seizure models that suggest that these biochemical and metabolic changes may decrease ictogenesis and epileptogenesis. A calorie-restricted diet might be effective in reducing seizures in people with epilepsy. Hence, there is a sufficient rationale to undertake clinical trials to assess the efficacy and safety of calorie-restricted diets in people with epilepsy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; Autophagy; Glucose; Intermittent fasting diet; Sirtuins; mTOR

Mesh:

Year:  2014        PMID: 24657501     DOI: 10.1016/j.yebeh.2014.02.026

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  21 in total

Review 1.  Impact of intermittent fasting on health and disease processes.

Authors:  Mark P Mattson; Valter D Longo; Michelle Harvie
Journal:  Ageing Res Rev       Date:  2016-10-31       Impact factor: 10.895

Review 2.  The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Paola Lenzi; Alessandro Frati; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

Review 3.  Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease.

Authors:  Annunziata Nancy Crupi; Jonathan Haase; Sebastian Brandhorst; Valter D Longo
Journal:  Curr Diab Rep       Date:  2020-12-10       Impact factor: 4.810

4.  Acute Fasting Regulates Retrograde Synaptic Enhancement through a 4E-BP-Dependent Mechanism.

Authors:  Grant Kauwe; Kazuya Tsurudome; Jay Penney; Megumi Mori; Lindsay Gray; Mario R Calderon; Fatima Elazouzzi; Nicole Chicoine; Nahum Sonenberg; A Pejmun Haghighi
Journal:  Neuron       Date:  2016-12-01       Impact factor: 17.173

5.  Increased Hippocampal Afterdischarge Threshold in Ketogenic Diet is Accompanied by Enhanced Kynurenine Pathway Activity.

Authors:  Bartosz Osuch; Karolina Kołosowska; Natalia Chmielewska; Danuta Turzyńska; Alicja Sobolewska; Janusz Szyndler; Piotr Maciejak
Journal:  Neurochem Res       Date:  2022-05-06       Impact factor: 3.996

Review 6.  How Does Fasting Affect Cognition? An Updated Systematic Review (2013-2020).

Authors:  Erik M Benau; Amanda Makara; Natalia C Orloff; Eleanor Benner; Lucy Serpell; C Alix Timko
Journal:  Curr Nutr Rep       Date:  2021-09-30

Review 7.  Ketogenic diet for epilepsy: an overview of systematic review and meta-analysis.

Authors:  Yue Ruan; Lian Chen; Dongli She; Yuehuan Chung; Long Ge; Lin Han
Journal:  Eur J Clin Nutr       Date:  2022-01-13       Impact factor: 4.884

8.  Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice.

Authors:  Joshua J Meidenbauer; Mary F Roberts
Journal:  Epilepsy Behav       Date:  2014-09-07       Impact factor: 2.937

Review 9.  Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy.

Authors:  Patricia Azevedo de Lima; Leticia Pereira de Brito Sampaio; Nágila Raquel Teixeira Damasceno
Journal:  Clinics (Sao Paulo)       Date:  2014-12       Impact factor: 2.365

10.  A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.

Authors:  Tsz Hong Law; Emma S S Davies; Yuanlong Pan; Brian Zanghi; Elizabeth Want; Holger A Volk
Journal:  Br J Nutr       Date:  2015-09-04       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.